Creo Medical Limited

LSE CREO.L

Creo Medical Limited Shares (Diluted, Weighted) for the year ending December 31, 2023: 313,004,399

Creo Medical Limited Shares (Diluted, Weighted) is 313,004,399 for the year ending December 31, 2023, a 66.59% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Creo Medical Limited Shares (Diluted, Weighted) for the year ending December 31, 2022 was 187,894,596, a 10.28% change year over year.
Creo Medical Limited Shares (Diluted, Weighted) for the year ending December 31, 2021 was 170,381,453, a 5.45% change year over year.
Creo Medical Limited Shares (Diluted, Weighted) for the year ending December 31, 2020 was 161,575,483, a 28.39% change year over year.
Creo Medical Limited Shares (Diluted, Weighted) for the year ending December 31, 2019 was 125,843,740, a 34.19% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

LSE: CREO.L

Creo Medical Limited

CEO	Mr. Craig Jonathan Gulliford
IPO Date	Dec. 9, 2016
Location	United Kingdom
Headquarters	Unit 2, Creo House
Employees	278
Sector	Health Care
Industries Medical Instruments Biotechnology

Description

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.

Key trends

Past 5 years